What's breaking now, across thousands of outlets.
Marea’s acquisition by Lisata, alongside a $225 million financing deal, will back development of a pair of medicines in mid-stage testing for cardiovascular and endocrine conditions.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
(MedPage Today) -- As the measles outbreak continues to spread in Pennsylvania, HHS Secretary Robert F. Kennedy Jr. on Thursday appeared before the vaccine skeptic group he used to lead and gave a…
(MedPage Today) -- A quarter of patients with cirrhosis from metabolic dysfunction-associated steatotic liver disease (MASLD) presented before the age of 50 and had distinct features, including…
The mining company is preparing to cut sod for a cutting-edge eight-bed emergency facility, along with a full-scale renovation of the hospital's existing wards, with work expected to commence before…
Better cardiovascular health (CVH) is nonlinearly and inversely associated with overactive bladder (OAB), according to a study published in the August issue of the Annals of Medicine & Surgery.
Pennsylvania's health department has started the process of requesting emergency assistance from the Centers for Disease Control and Prevention (CDC) to help control a deadly and rapidly spreading…
Addressing the media as part of activities to mark the 2026 National Patient Safety Day, Dr Adomako Boateng said non-communicable diseases account for about 40 percent of all deaths, making early…
